These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4616842)

  • 1. Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow.
    Buckner CD; Clift RA; Fefer A; Neiman PE; Storb R; Thomas ED
    Exp Hematol; 1974; 2(3):138-46. PubMed ID: 4616842
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow.
    Buckner CD; Stewart P; Clift RA; Fefer A; Neiman PE; Singer J; Storb R; Thomas ED
    Exp Hematol; 1978 Jan; 6(1):96-109. PubMed ID: 342261
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous bone-marrow and peripheral blood buffy coat cell infusion in the treatment of chronic myeloid and acute leukemia.
    Mahmood T; Robinson WA; Entringer M
    Exp Hematol; 1979; 7 Suppl 5():321-6. PubMed ID: 400695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow transplantation for stable-phase chronic granulocytic leukemia.
    Armitage JO; Klassen LW; Patil SR; Kugler JW; Gingrich RD; Ahmann GB; Fyfe MA; Tewfik HH
    Exp Hematol; 1984 Oct; 12(9):717-9. PubMed ID: 6386509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?
    Vellenga E; van Putten WL; Boogaerts MA; Daenen SM; Verhoef GE; Hagenbeek A; Jonkhoff AR; Huijgens PC; Verdonck LF; van der Lelie J; Schouten HC; Gmür J; Wijermans P; Gratwohl A; Hess U; Fey MF; Löwenberg B
    Bone Marrow Transplant; 1999 Jun; 23(12):1279-82. PubMed ID: 10414916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
    Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
    Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin.
    Fefer A; Cheever MA; Thomas ED; Boyd C; Ramberg R; Glucksberg H; Buckner CD; Storb R
    N Engl J Med; 1979 Feb; 300(7):333-7. PubMed ID: 366408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Granulocytic progenitors in bone marrow autografts].
    Maraninchi D; Sebahoun G; Chauvet M; Gastaut JA; Novakovitch G; Kulling G; de Chesse R; Forgues L; Mascret B; Carcassonne Y
    Nouv Rev Fr Hematol (1978); 1983; 25(4):235-9. PubMed ID: 6353372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous marrow transplantation after karyotypic conversion to normal in blastic phase of chronic myelocytic leukemia.
    Vogler WR; Winton EF; James S; O'Neill S; Granade S; Mallard G
    Am J Med; 1983 Dec; 75(6):1080-4. PubMed ID: 6359875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
    Friedberg JW; Neuberg D; Gribben JG; Mauch P; Anderson KC; Soiffer RJ; Takvorian T; Fisher DC; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman AS
    Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [High-dose cyclophosphamide and whole-body radiotherapy followed by bone marrow transplant in patients with leukemia].
    Fernández-Rañada JM; Vázquez L; Lozano M; Fernández-Garese D; Figuera A; Arranz R; González N; Gómez N; Fernández Villalta MJ; Gómez-Reino F
    Rev Clin Esp; 1987 Mar; 180(5):247-52. PubMed ID: 3299537
    [No Abstract]   [Full Text] [Related]  

  • 13. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
    Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
    Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in chronic myelogenous leukemia.
    Stryckmans PA
    Semin Hematol; 1974 Apr; 11(2):101-27. PubMed ID: 4595812
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical conference: Myelosclerosis and chronic myeloid leukemia].
    Waitz R; Mayer S; Mayer G; Oberling F
    Nouv Rev Fr Hematol; 1975; 15(2):213-28. PubMed ID: 126431
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and cryopreservation of granulomonocytic colony forming cells (GM-CFC) from the blood of patients with chronic granulocytic leukemia (CGL) for autologous transplantation.
    Berthier R; Douady F; Kaufmann A; Arvieux J; Michallet M; Sotto JJ; Newton IA; Lajmanovich A; Schweitzer A; Chagnon E; Thevenon D; Hollard D
    Exp Hematol; 1982 Aug; 10(7):578-86. PubMed ID: 6957307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Jerjis S; Roovers E; Muus P; Schaap N; de Witte T
    Bone Marrow Transplant; 1998 Jul; 22(1):13-9. PubMed ID: 9678790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation in chronic myelogenous leukemia.
    Reiffers J
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):509-20. PubMed ID: 3912928
    [No Abstract]   [Full Text] [Related]  

  • 19. Autografting cryopreserved buffy coat cells for chronic granulocytic leukaemia in transformation.
    Goldman JM
    Exp Hematol; 1979; 7 Suppl 5():389-97. PubMed ID: 299447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M; Andersson B; Khouri I; Giralt S; Rios MB; Champlin R; Hester J; Deisseroth AB
    Bone Marrow Transplant; 1994 Jul; 14(1):57-61. PubMed ID: 7951120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.